01 May 2020 --- The US Food and Drug Administration (FDA) has authorized seven claims for Lactium, an Ingredia brand of milk protein hydrolysate. Lactium is touted as managing stress and its related disorders as it contains a bioactive decapeptide with relaxing properties, called alpha-casozepine. The dietary supplements manufacturers featuring Lactium in their products for adults will now be able to communicate on-pack about the benefits of this bioactive.
